Rituximab-Related Late-Onset Neutropenia After Autologous Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphoma

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1704467
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Infections Following Autologous Stem Cell Transplantation for Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Late-Onset Neutropenia After Rituximab Treatment for Adult-Onset Nephrotic Syndrome

Case Reports in Nephrology
2019English

Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients With Non-Hodgkin's Lymphoma (NHL)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Remission and Relapse of Crohn's Disease Following Autologous Haematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Gut
Gastroenterology
2007English

Ulcerative Colitis After Autologous Peripheral Blood Stem Cell Transplantation for Non-Hodgkin’s Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2001English

Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply

The Lancet Oncology
Oncology
2017English

Autologous Stem Cell Transplantation in Elderly (>60 Years) Patients With Non-Hodgkin's Lymphoma: A Nation-Wide Analysis

Bone Marrow Transplantation
TransplantationHematology
2006English

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy